Skip to Main Content

Paper Details

Nirmatrelvir Plus Ritonavir for Ambulatory COVID-19: Expanding Evidence, Expanding Role.
Ann Intern Med
2
2023
Author NameAffiliation
George L AnesiUniversity of Pennsylvania Perelman School of Medicine
  • 1 - 1

Datasets

Release 1.2